BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6120738)

  • 41. Dyspepsia: incidence of a non-ulcer disease in a controlled trial of ranitidine in general practice.
    Saunders JH; Oliver RJ; Higson DL
    Br Med J (Clin Res Ed); 1986 Mar; 292(6521):665-8. PubMed ID: 3081221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.
    Walan A; Bader JP; Classen M; Lamers CB; Piper DW; Rutgersson K; Eriksson S
    N Engl J Med; 1989 Jan; 320(2):69-75. PubMed ID: 2643037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of gastric ulcer with ranitidine.
    Schulz TB; Berstad A; Rydning A; Frislid K
    Scand J Gastroenterol; 1984 Jan; 19(1):119-21. PubMed ID: 6324332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
    Sevvel S; Ananthakrishnan N; Kate V
    Trop Gastroenterol; 1996; 17(4):227-9. PubMed ID: 9094865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Famotidine versus ranitidine in the acute treatment of duodenal ulcer. A multicenter comparative study in Germany].
    Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
    Z Gastroenterol; 1985 Feb; 23(2):47-51. PubMed ID: 2865859
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ranitidine in the treatment of gastric ulceration.
    Wright JP; Marks IN; Mee AS; Girdwood AH; Bornman PC; Gilinsky NH; Tobias P; Lucke W
    S Afr Med J; 1982 Jan; 61(5):155-8. PubMed ID: 6277019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease.
    Korman MG; Hansky J; Eaves ER; Schmidt GT
    Gastroenterology; 1983 Oct; 85(4):871-4. PubMed ID: 6136450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Review of peptic ulcer maintenance trials.
    Robinson M
    Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A double-blind comparison of cimetidine and ranitidine as prophylaxis against gastric aspiration syndrome.
    Morison DH; Dunn GL; Fargas-Babjak AM; Moudgil GC; Smedstad K; Woo J
    Anesth Analg; 1982 Dec; 61(12):988-92. PubMed ID: 6128946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral ranitidine for prophylaxis against Mendelson's syndrome.
    Francis RN; Kwik RS
    Anesth Analg; 1982 Feb; 61(2):130-2. PubMed ID: 6119931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Ranitidine in the treatment of duodenal ulcer. Initial clinical experience with 33 patients].
    Noya G; Dettori G; Antona C; Niolu P; Muscas A; Marongiu G; Biglioli P
    Minerva Med; 1983 Mar; 74(13):691-3. PubMed ID: 6132353
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ranitidine in the treatment of duodenal and prepyloric ulcer: comparison of two dosage regimens.
    Brunner H; Pesendorfer FX; Pötzi R
    J Int Med Res; 1983; 11(3):167-72. PubMed ID: 6307772
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
    Chelvam P; Wong EC
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
    McKenna CJ; Mills JG; Goodwin C; Wood JR
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Is strong inhibition of gastric acid in the treatment of peptic ulcer sensible?].
    de Bruijne JW; Lamers CB
    Ned Tijdschr Geneeskd; 1989 Apr; 133(13):657-62. PubMed ID: 2566125
    [No Abstract]   [Full Text] [Related]  

  • 56. A single night time dose of ranitidine in the acute treatment of gastric ulcer: a European multicentre trial.
    Ryan FP; Jorde R; Ehsanullah RS; Summers K; Wood JR
    Gut; 1986 Jul; 27(7):784-8. PubMed ID: 3525337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Modified H2 receptor blockers in ulcus therapy].
    Domschke S; Domschke W
    Dtsch Med Wochenschr; 1982 Dec; 107(48):1827-30. PubMed ID: 6128214
    [No Abstract]   [Full Text] [Related]  

  • 58. Ranitidine in the treatment of gastric, prepyloric and duodenal ulcer--a controlled prospective double-blind trial.
    Darle N; Almskog B; Falk A; Fredriksen B; Gamklou R; Ivarsson L; Karlström L
    Ann Clin Res; 1984; 16(1):6-9. PubMed ID: 6331270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
    Yeomans ND; Tulassay Z; Juhász L; Rácz I; Howard JM; van Rensburg CJ; Swannell AJ; Hawkey CJ
    N Engl J Med; 1998 Mar; 338(11):719-26. PubMed ID: 9494148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer.
    Van Deventer GM; Elashoff JD; Reedy TJ; Schneidman D; Walsh JH
    N Engl J Med; 1989 Apr; 320(17):1113-9. PubMed ID: 2651924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.